Abbvie Inc NYSE:ABBV:
SKYRIZI® (RISANKIZUMAB-RZAA) NOW FDA APPROVED FOR PEDIATRIC USE IN PSORIATIC DISEASE
Reuters
Skyrizi® (Risankizumab-Rzaa) Now FDA Approved For Pediatric Use In Psoriatic Disease
- Sources
- Reuters
- Markets
- Stocks
- Active symbols
- NYSE:ABBV
- Language
- English
Abbvie Inc NYSE:ABBV: